36 participants
Combined HAIC, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-22
- Start Date:
- 2024-06-04
- Completion:
- 2028-06-30
Conditions
- Cholangiocarcinoma Non-resectable
Interventions
- PROCEDURE
- DRUG
No Results Yet